About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, obesity, or other conditions, according to a KFF Health Tracking poll. But many suffer from significant side effects including nausea or vomiting. And for diabetic patients who also have conditions such as cancer or HIV, achieving glycemic control to effectively manage their blood sugar levels while avoiding weight or appetite loss is especially critical.
This article was originally published on MedicalXpress.com
